The RIQAS Anti-SARS-CoV-2 EQA programme comprises IgG, IgM and total antibodies. This programme uniquely supports both qualitative and quantitative reporting.
- Liquid ready-to-use
- 100% human plasma provides a commutable sample matrix
- Monthly reporting – 1 sample per month
- Submit results and view reports online via RIQAS.Net
- Qualitative and Quantitative reporting options available
- Rapid report turnaround allows any necessary corrective actions to be made with minimal disruption
- Allows comparison of different methodologies
Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
---|---|---|---|---|---|
RQ9193 | 2 x (6 x 0.5mL) | Monthly (1 sample per month) - 2 distributions per year | October | 3 parameters | |
Parameters
- IgG
- IgM
- Total Antibodies
Please note, product availability may vary country to country.